UBS Starts Alkermes (ALKS), Par Pharma (PRX) at Buy, Salix Pharma (SLXP) at Neutral
Tweet Send to a Friend
An analyst at UBS initiated coverage on stocks in the Biotech ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
